Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy

被引:2
|
作者
Esen, Ebru [1 ]
Sizmaz, Selcuk [1 ]
Demircan, Nihal [1 ]
机构
[1] Cukurova Univ, Sch Med, Dept Ophthalmol, Adana, Turkey
关键词
Central serous chorioretinopathy; Photodynamic therapy; Optical coherence tomography; Outer nuclear layer; Choroidal thickness; OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; PHOTORECEPTOR OUTER SEGMENT; MORPHOLOGIC CHANGES; NUCLEAR LAYER; VERTEPORFIN; EYES; OUTCOMES;
D O I
10.1016/j.pdpdt.2021.102347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate the retinal and choroidal microstructural changes at fovea after half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC), using optical coherence tomography (OCT). Methods: The study included 35 eyes with unilateral chronic CSC treated with half-dose PDT. The foveal outer nuclear layer (ONL) and subfoveal choroidal thickness (SFCT) in the affected eyes were compared with baseline measurements at month 1, 3, and 6 after half-dose PDT, and those of the healthy contralateral eyes. Results: The mean baseline ONL thickness of the affected eyes was thinner compared to unaffected fellow eyes (66.9 +/- 16.5 mu m vs 111.5 +/- 11.6 mu m, p<0.001), and increased significantly to 68.6 +/- 17.0 mu m at month 3 and 68.9 +/- 17.3 mu m at month 6 after treatment (p = 0.025 and p = 0.014 respectively). The mean baseline SFCT of the affected eyes was thicker compared to unaffected fellow eyes (399.9 +/- 87.0 mu m vs 338.2 +/- 75.4 mu m, p<0.001), and decreased significantly after treatment at month 1, 3, and 6 (374.0 +/- 84.8 mu m, 369.7 +/- 81.8 mu m, 367.3 +/- 80.8 mu m respectively, p<0.001 for all). The responder group (n = 26), in which subretinal fluid was completely resorbed, showed a significant increase in ONL thickness and decrease in SFCT after treatment, whereas in the non-responder group (n = 9) ONL thickness and SFCT did not differ after treatment. Conclusions: In CSC patients, significant changes are observed in foveal ONL thickness and SFCT after half-dose PDT. ONL thickness and SFCT are suggested to be considered in the OCT examinations of CSC patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
    Tseng, Chien-Chi
    Chen, San-Ni
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (08) : 1070 - 1077
  • [22] Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
    Uetani, R.
    Ito, Y.
    Oiwa, K.
    Ishikawa, K.
    Terasaki, H.
    EYE, 2012, 26 (05) : 641 - 648
  • [23] Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy
    Liu, Hsin-Yu
    Yang, Chang-Hao
    Yang, Chung-May
    Ho, Tzyy-Chang
    Lin, Chang-Ping
    Hsieh, Yi-Ting
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 167 : 57 - 64
  • [24] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Oiwa, Kazuhiro
    Kataoka, Keiko
    Maruko, Ruka
    Ueno, Shinji
    Ito, Yasuki
    Terasaki, Hiroko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (03) : 260 - 266
  • [25] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Kazuhiro Oiwa
    Keiko Kataoka
    Ruka Maruko
    Shinji Ueno
    Yasuki Ito
    Hiroko Terasaki
    Japanese Journal of Ophthalmology, 2017, 61 : 260 - 266
  • [26] The safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, H. M. A.
    Diederen, R. M. H.
    Lamme, M. J. C. M.
    Fauser, S.
    Downes, S. M.
    Schlingemann, R. O.
    Hoyng, C. B.
    van Dijk, E. H. C.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 19 - 19
  • [27] Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
    Etsuyo Horiguchi
    Jun Takeuchi
    Ryo Tomita
    Keiko Asai
    Yuyako Nakano
    Hikaru Ota
    Yosuke Taki
    Yasuki Ito
    Hiroko Terasaki
    Koji M. Nishiguchi
    Keiko Kataoka
    Scientific Reports, 12
  • [28] Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
    Ratanasukon, Mansing
    Thongthong, Koblarp
    Bhurayanontachai, Patama
    Jirarattanasopa, Pichai
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 87 - 92
  • [29] Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy
    Hoehn, F.
    Kretz, F. T. A.
    Beger, I.
    Koch, F.
    Auffarth, G. U.
    Singh, P.
    Deuchler, S.
    Koss, M. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (07) : 860 - 863
  • [30] Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
    Horiguchi, Etsuyo
    Takeuchi, Jun
    Tomita, Ryo
    Asai, Keiko
    Nakano, Yuyako
    Ota, Hikaru
    Taki, Yosuke
    Ito, Yasuki
    Terasaki, Hiroko
    Nishiguchi, Koji M.
    Kataoka, Keiko
    SCIENTIFIC REPORTS, 2022, 12 (01)